Journavx has been specifically approved for the treatment of moderate-to-severe acute pain, which often results from injury, surgery, illness, trauma or painful medical procedures, and typically …
https://www.newsweek.com/what-journavx-first-pain-med-approved-fda-two-decades-2023944

